ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï±î?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
Á¦8ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²² ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¾ö
¾È³çÇϽʴϱî
ÃÖ±Ù 10³â »çÀÌ carbapenem-resistant non-fermenter, carbapenem-resistant Enterobacteriaceae(CRE)°¡ ±Þ°ÝÇÏ°Ô ´Ã¾î³ª¸é¼ À̵é multidrug-resistant organisms¿¡ ÀÇÇÑ ÀÇ·á°ü·Ã°¨¿°ÀÌ Å« ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼, 2018³â 6¿ù¿¡ ¹ßÇ¥µÈ ÀÇ·á°ü·Ã°¨¿° ¿¹¹æ°ü¸® Á¾ÇÕ´ëÃ¥ (2018-2022)¿¡¼´Â CRE ¹ß»ý·üÀ» Çö ¼öÁØÀ¸·ÎºÎÅÍ 20% Á¤µµ ÁÙÀ̰ڴٴ °èȹÀ» ¹ßÇ¥Çϱ⵵ ÇÏ¿´°í, °¢ º´¿ø¿¡¼ ÀÌ·¯ÇÑ multidrug-resistant gram-negative bacterial infectionsÀÇ ¹ß»ýÀ» ÁÙÀ̱â À§ÇØ º¸´Ù ¼¼¹ÐÇÑ °¨¿°°ü¸® Àü·«°ú ´õºÒ¾î ÀûÀýÇÑ Ç×»ýÁ¦ÀÇ »ç¿ë, ±×¸®°í regional coordinated approach °¡ ¿ä±¸µÇ°Ú½À´Ï´Ù.
"Á¦8ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²² ÇÏ´Â ½ÉÆ÷Áö¾ö"¿¡¼´Â multidrug-resistant gram-negative bacterial infections °ü¸®¿¡ ÁýÁßÇÏ¿© infection control, antimicrobial stewardship »Ó ¾Æ´Ï¶ó ÃÖ±Ù »õ·Ó°Ô Á¶¸í¹Þ°í ÀÖ´Â fecal microbiota transplantation µî¿¡ ´ëÇØ ¹è¿ì´Â ½Ã°£À» °®°íÀÚ ÇÕ´Ï´Ù. ÇÑÆí, Áß¼Òº´¿ø ¹× Àå±â¿ä¾çº´¿ø¿¡¼ÀÇ ½ÇÁ¦ÀûÀÎ multidrug-resistant gram-negative bacterial infections °¨¿°°ü¸®ÀÇ ¼ÒÁßÇÑ °æÇèÀ» °øÀ¯ÇÏ¿© °¢ Áö¿ª»çȸº´¿ø¿¡µµ ½ÇÁúÀûÀÎ µµ¿òÀÌ µÉ ¼ö ÀÖµµ·Ï ÇÁ·Î±×·¥À» ÁغñÇÏ¿´½À´Ï´Ù.
ºÎµð ¹Ù»Ú½Å °¡¿îµ¥¿¡¼ Á¦8ȸ "Áö¿ª»çȸº´¿ø°ú ÇÔ²² ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¾ö"¿¡ Âü¼®ÇØ ÁÖ½Å´Ù¸é ¼±»ý´Ôµé²²¼ ±Ù¹«ÇϽô º´¿øÀÇ °¨¿°°ü¸®¿¡ Å« µµ¿òÀÌ µÉ °ÍÀ̶ó È®½ÅÇϸç, ¼±»ý´Ôµé²² ÃÊ´ëÀÇ ±ÛÀ» ¿Ã¸³´Ï´Ù.
2018³â 11¿ù
ÇѸ²´ëÇб³¼º½Éº´¿ø °¨¿°³»°ú ºÐ°úÀå À̽¼ø ¿Ã¸²
±¸ºÐ | Àü¹®ÀÇ/ÀüÀÓÀÇ | Àü°øÀÇ/°£È£»ç |
---|---|---|
»çÀüµî·Ï | 2¸¸¿ø | 1¸¸¿ø |
ÇöÀåµî·Ï | 3¸¸¿ø | 2¸¸¿ø |
½Ã°£ | Á¦¸ñ | °»ç |
---|---|---|
Session 1 | ÁÂÀå- ÇѸ²ÀÇ´ë ¿ìÈïÁ¤ | |
14:00-14:35 | CRE °ü¸® ¾î¶»°Ô ÇØ¾ßÇÒ±î?; defensive and offensive measures | °¡Å縯ÀÇ´ë À¯ÁøÈ« |
14:35-15:10 | ´Ù¸éÀû ÁßÀç Àü·«À» ÅëÇÑ ÁßȯÀڽǿ¡¼ÀÇ CRAB °¨¿°°ü¸® | °æ»óÀÇ´ë ¹èÀÎ±Ô |
15:10-15:45 | fecal microbiota transplantation½ÃÇàÀÇ À¯¿ë¼º°ú Áغñ | ¿¬¼¼ÀÇ´ë ¿ëµ¿Àº |
15:45-16:05 | Coffee Break | |
Session 2 | ÁÂÀå- ÇѸ²ÀÇ´ë ¼Û¿ø±Ù | |
16:05-16:40 | Ä«¹ÙÆä³Û ³»¼º ±×¶÷À½¼º±Õ °¨¼Ò¸¦ À§ÇÑ antimicrobial stewardship: carbapenem-sparing strategies | ÇѸ²ÀÇ´ë À̽¼ø |
16:50-17:15 | Áß¼ÒÁ¾ÇÕº´¿ø¿¡¼ÀÇ ´ÙÁ¦³»¼º ±×¶÷À½¼º±Õ °¨¿°°ü¸®ÀÇ ½ÇÁ¦ | ±¤¸í¼º¾Öº´¿ø ±â¼¼À± |
17:15-17:50 | Àå±â¿ä¾çº´¿ø¿¡¼ÀÇ ´ÙÁ¦³»¼º ±×¶÷À½¼º±Õ °¨¿°°ü¸®ÀÇ ½ÇÁ¦ | ¸ÞµðÇÏÀÓÈ¿º´¿ø ±è¿ìÅà |